Is an A1C of 5.8 Bad? What This Prediabetes Level Means

An A1C of 5.8% sits just inside the prediabetes range, which the American Diabetes Association defines as 5.7% to 6.4%. It is not diabetes, and it is not a medical emergency, but it does signal that your body is handling blood sugar less efficiently than it should. The good news is that 5.8% is the shallow end of prediabetes, and the evidence strongly suggests this level is responsive to straightforward lifestyle changes. The less reassuring part is that prediabetes at any level carries some added health risks beyond just the possibility of eventually developing type 2 diabetes.

Where 5.8% Falls on the Risk Spectrum

Not all prediabetes is equal. A systematic review of 16 studies found that the risk of developing diabetes climbs steeply across the A1C range of 5.0% to 6.5%, but the gradient matters a lot. People with an A1C between 5.5% and 6.0% had a moderately increased risk, with roughly 9% to 25% developing diabetes over five years. Compare that to the 6.0% to 6.5% range, where five-year diabetes incidence jumped to 25% to 50%.¹ At 5.8%, you are closer to the lower-risk portion of the prediabetes window.

A study of older adults with prediabetic A1C levels (5.7% to 6.4%) tracked outcomes over several years and found that only about 9% progressed to diabetes. Meanwhile, 13% actually regressed back to normal blood sugar levels, and the majority, around 59%, stayed right where they were.² That paints a more nuanced picture than the alarm many people feel when they first see the word “prediabetes” on their lab results. Progression is not inevitable, and for a meaningful number of people, blood sugar levels drift back down on their own.

That said, yearly conversion rates from prediabetes to diabetes run between 5% and 10% according to a broad review of international data, and the risk compounds over time.³ Sitting at 5.8% for a decade without any changes is a different story than catching it early and taking action.

What Is Actually Happening in Your Body

A1C measures the percentage of hemoglobin in your red blood cells that has glucose attached to it, reflecting your average blood sugar over the past two to three months. At 5.8%, the picture is one of early metabolic strain. Two things are typically going wrong to varying degrees: your cells are becoming less responsive to insulin (insulin resistance), and the beta cells in your pancreas that produce insulin are beginning to work less effectively.⁴ Your body can still keep blood sugar mostly in check, but the machinery is working harder than it should.

Research in newly diagnosed, untreated type 2 diabetes patients offers a window into how this deterioration scales. At A1C levels just above the diabetes threshold, beta cell function actually increases temporarily as the pancreas overcompensates. But as A1C rises further, beta cell function drops sharply. At an A1C of 9% or above, beta cell function was reduced by about 62% compared to people with lower levels.⁵ At 5.8%, you are nowhere near that level of decline. The metabolic changes are subtle, which is precisely why intervention now has the best chance of working.

Heart and Blood Vessel Risks at This Level

The conversation about prediabetes often focuses entirely on whether you will eventually develop diabetes. But the cardiovascular risks deserve attention in their own right. Prediabetes is associated with early vascular changes including increased arterial stiffness and impaired blood vessel function. One particularly striking finding from the Multi-Ethnic Study of Atherosclerosis showed that prediabetes was linked to a nearly three-fold higher rate of unrecognized heart attacks compared to people with normal blood sugar.⁶

A large Canadian study of over 600,000 adults looked specifically at whether A1C levels in the 5.5% to 5.9% range, which spans from “normal” into early prediabetes, carried cardiovascular risk. Men in this range had about a 12% higher risk of cardiovascular hospitalization compared to men with A1C levels of 5.0% to 5.4%. Interestingly, the same association was not found in women.⁷ The sex difference is not fully explained, but it reinforces the idea that even small elevations in blood sugar may matter for long-term cardiovascular health, particularly in men.

Does Prediabetes Actually Shorten Your Life?

The mortality data on prediabetes is genuinely mixed, and the answer depends partly on your age and what other health conditions you have. A 40-year follow-up study from Israel found that prediabetes was associated with about two fewer years of life expectancy after adjusting for other risk factors like smoking, blood pressure, and weight.⁸ A national study from China also found a small but statistically significant association between prediabetes and increased all-cause mortality.⁹

But a study focused specifically on older adults found that after adjusting for other cardiovascular risk factors, prediabetes was not significantly associated with higher mortality risk over a median follow-up of about five and a half years.¹⁰ The takeaway is that prediabetes by itself, at the lower end of the range where 5.8% sits, is probably not an independent death sentence. The danger is more about the company it keeps: excess weight, high blood pressure, elevated cholesterol, and inactivity often travel together with mildly elevated blood sugar, and the combination is what drives risk.

Why Your A1C Result Might Not Be Perfectly Accurate

A1C is a convenient test, but it has real limitations that matter at the margins, and 5.8% is very much at the margins. The test measures glucose attached to hemoglobin, so anything that affects your red blood cells or hemoglobin can skew the result.

Iron deficiency anemia is one of the most common confounders. Research has found that people with iron deficiency tend to have artificially elevated A1C readings. In one study, iron-deficient individuals had a mean A1C of 6.8% compared to controls, and the elevation was even more pronounced in women.¹¹ Anemia also reduces the specificity of A1C as a diagnostic tool, meaning the test is more likely to flag someone as prediabetic or diabetic when they are not.¹² If you are anemic, especially if you are a woman of reproductive age or have chronic iron deficiency, a 5.8% A1C reading may overstate your actual blood sugar situation.

Other conditions that can affect A1C include hemoglobin variants (more common in people of African, Mediterranean, or Southeast Asian descent), chronic kidney disease, recent blood transfusions, and pregnancy. If something about your health picture does not line up with a prediabetes reading, it is worth asking your doctor about confirmatory testing.

The Problem With Using A1C Alone

A1C, fasting glucose, and the oral glucose tolerance test (OGTT) are all accepted ways to diagnose prediabetes, but they do not always agree. A study of over 7,400 U.S. adults found that overall agreement between these three tests was low, with a substantial percentage of cases classified differently depending on which test was used.¹³ In younger populations, the discordance can be even worse. A study in overweight and obese youth found that A1C alone had only 70% sensitivity and under 49% specificity for prediabetes when compared to the OGTT.¹⁴

This does not mean A1C is useless. It is still a practical, widely available, no-fasting-required screening tool. But if your result is borderline, a fasting glucose or OGTT can provide a fuller picture. Some researchers have argued that the strongest diagnostic confidence comes when A1C and fasting glucose agree. The older adult study cited earlier found that the highest progression rate to diabetes occurred in people who met both the A1C and fasting glucose criteria for prediabetes simultaneously.²

Race and Ethnicity Change What 5.8% Means

This is an area where the science is genuinely uncomfortable. A1C levels vary by race and ethnicity even when blood sugar measured directly is the same. Data from the Diabetes Prevention Program showed that among people with identical glucose tolerance test results, mean A1C was 5.78% in white participants, 5.93% in Hispanic participants, 6.00% in Asian participants, 6.12% in American Indian participants, and 6.18% in Black participants, even after adjusting for age, sex, weight, blood pressure, fasting glucose, and insulin resistance.¹⁵

Research using U.S. population data has found that the optimal A1C cutoff for distinguishing prediabetes from normal was consistently higher in Black adults compared to white adults. For detecting prediabetes versus normal, the best cutoff was 5.7% in Black participants versus 5.5% in white participants.¹⁶ A scoping review further noted that the standard cutoffs were derived primarily from white population cohorts and may lead to overdiagnosis in African Americans, who tend to have higher A1C values at equivalent glucose levels, and underdiagnosis in some African immigrant populations, who may have lower values.¹⁷

What this means practically: if you are a Black American with an A1C of 5.8%, your reading might represent a glucose reality equivalent to a white person’s 5.5% or 5.6%. It does not mean you should ignore the result, but it does mean the interpretation is not as straightforward as a single universal cutoff implies. Discussing this with your doctor, especially if a fasting glucose or OGTT tells a different story, is reasonable.

Age Matters Too

A1C tends to creep upward with age even in people with perfectly normal glucose tolerance. Analysis from the Framingham Offspring Study and national survey data found that A1C rises by about 0.01 percentage points per year of age in people without diabetes.¹⁸ That seems tiny, but over decades it adds up. A healthy 70-year-old might naturally sit at a higher A1C than a healthy 30-year-old without any difference in disease risk. The researchers who uncovered this relationship suggested that age-specific diagnostic cutoffs might eventually be appropriate, though current clinical guidelines have not adopted them.

For a 35-year-old, an A1C of 5.8% deserves more attention than the same reading in a 70-year-old, because the younger person’s reading is less likely to be explained by normal aging and more likely to reflect genuine metabolic change.

The Evidence for Lifestyle Change

If there is one bright spot in the prediabetes landscape, it is the strength of the evidence for lifestyle intervention. The landmark Diabetes Prevention Program trial showed that a structured lifestyle program, focused on modest weight loss (about 7% of body weight) and at least 150 minutes per week of physical activity, reduced the incidence of diabetes by 58% compared to placebo. To prevent one case of diabetes over three years, only about seven people needed to participate in the lifestyle program.¹⁹ That is a remarkably effective intervention by any medical standard.

A systematic review and meta-analysis of studies on reversing prediabetes found strong evidence that lifestyle modification helps people return to normal blood sugar. At a median follow-up of about a year and a half, roughly 18 more participants out of every 100 in lifestyle modification groups achieved normal blood sugar compared to controls. The evidence was rated as strong.²⁰

The long-term follow-up from the Diabetes Prevention Program confirmed that these benefits persist, though they do fade somewhat. After 15 years, the lifestyle group still showed a 27% reduction in diabetes development compared to placebo.²¹ The fact that the benefit diminished over time is actually a reminder that the lifestyle changes need to be sustained. A short burst of exercise followed by a return to old habits does not provide lasting protection.

What Kind of Exercise Helps Most

Both aerobic exercise and resistance training improve insulin sensitivity in people with elevated blood sugar, but there is evidence that resistance training deserves more emphasis than it typically gets. A study comparing treadmill exercise to resistance training in adults with type 2 diabetes found that both lowered A1C, but the resistance training group achieved significantly greater reductions. After 10 weeks, 40% of the resistance training group had reached target A1C levels, compared to none in the treadmill group.²² While that study was in people who already had diabetes, the mechanism is relevant for prediabetes: building muscle mass increases the total volume of tissue that can absorb glucose from the bloodstream.

For people who find traditional cardio boring or difficult, sprint interval training may be another option. A trial in men with prediabetes found that both traditional aerobic exercise and short-burst sprint intervals significantly reduced insulin resistance and improved A1C over three months.²³ The practical message: the best exercise type is the one you will actually do consistently. If that is walking, walk. If it is lifting weights or doing short intense bursts, those work too.

Diet Beyond the Usual Advice

You already know the general script: eat fewer refined carbohydrates, more vegetables, watch your portions. The research supports that broad approach, but some specific dietary patterns are worth noting. A randomized trial comparing a healthy Nordic diet (emphasizing whole grains, fish, legumes, and berries) to usual care in people with type 2 diabetes or prediabetes found that the Nordic diet led to greater reductions in both body weight and A1C than usual care.²⁴ This matters because it highlights that the overall pattern of eating probably matters more than any single food swap.

On the other hand, not every trendy dietary intervention pans out. A crossover trial testing pistachio consumption as an evening snack in adults with prediabetes found no difference in fasting glucose, A1C, insulin resistance, or lipids compared to a control snack approach.²⁵ Individual food additions are rarely transformative. The overall dietary pattern, combined with weight management, is what moves the needle.

The Metformin Question

Some doctors will suggest metformin for prediabetes, and there is real disagreement among experts about whether this is appropriate, especially at the lower end of the range. In the Diabetes Prevention Program, metformin reduced diabetes incidence by 31% compared to placebo, which is meaningful but roughly half as effective as the lifestyle intervention.¹⁹ And after 15 years, the metformin group’s cumulative diabetes incidence (56%) was nearly the same as the lifestyle group’s (55%), both better than placebo (62%).²¹

A prominent counterargument, laid out in a published position paper, contends that metformin should not be used for prediabetes. The reasoning: about two-thirds of people with prediabetes never develop diabetes anyway, about a third return to normal on their own, and people at this blood sugar level are not at risk for the small-vessel complications (eye, kidney, nerve damage) that diabetes causes. The paper argues that putting people on a drug potentially for life to lower already-subdiabetic blood sugar to even lower levels is hard to justify. It suggests reserving close monitoring and immediate metformin use for those at highest risk, specifically people with fasting glucose of 110 to 125 mg/dL or A1C of 6.0% to 6.4%, and women with a history of gestational diabetes.²⁶

At an A1C of 5.8%, you fall below those higher-risk cutoffs. For most people at this level, lifestyle changes are the first-line recommendation. Metformin becomes a more reasonable conversation if your A1C continues to climb despite real effort, or if you have other strong risk factors like a family history of diabetes or a history of gestational diabetes.

What Continuous Glucose Monitors Are Revealing

Continuous glucose monitors, small sensors worn on the skin that track blood sugar every few minutes, are increasingly being used by people with prediabetes, not just those with full-blown diabetes. The data they generate can be eye-opening. A study of a community-based cohort found that people with prediabetes spent almost 20% of their time in the elevated range of 140 to 180 mg/dL, and more than 3% of the time, or over 45 minutes per day, above 180 mg/dL.²⁷ An A1C of 5.8% is an average, and averages hide spikes. You could have perfectly normal blood sugar most of the day and sharp peaks after certain meals that your A1C number smoothes out.

Emerging research suggests that glucose variability, the size of the swings rather than just the average level, may be important for identifying who is at higher risk of progressing. One analysis found that variability indices could identify people with prediabetes even when their average continuous glucose reading was normal, and that higher variability may signal greater risk of progression to diabetes.²⁸ CGM is still far from routine for prediabetes, but it offers a level of detail that a single A1C reading cannot.

Sleep and Circadian Rhythms

There is growing evidence that how well your internal clock is functioning affects blood sugar regulation in prediabetes. A study of people with prediabetes found that shorter sleep duration was associated with higher A1C, and that a less robust 24-hour rest-activity rhythm, meaning less contrast between active daytime and restful nighttime, was independently linked to higher A1C even after accounting for age, sex, weight, and sleep duration.²⁹ Irregular sleep schedules, night shift work, and sleep disorders like sleep apnea all disrupt circadian patterns. Addressing these is not typically the first thing doctors mention when discussing prediabetes, but the research suggests it should be part of the conversation.

The Psychological Side of a Prediabetes Diagnosis

Getting labeled with a medical condition, even a “pre” condition, takes a real psychological toll that the clinical conversation often glosses over. A controlled study found that people with prediabetes scored significantly worse on measures of fatigue, anxiety, and depression compared to people with normal blood sugar. Their overall quality of life scores were also substantially lower.³⁰ A separate cross-sectional study found that the prevalence of moderate to severe depression and anxiety was actually highest in the prediabetes group, even higher than in people with established type 2 diabetes.³¹

Some of this may be biological. Insulin resistance and blood sugar fluctuations can affect brain chemistry and energy levels. But some is almost certainly the anxiety of living in a gray zone: you know something is wrong, but the condition feels vague and the path forward is uncertain. If you find yourself overly anxious or down after a prediabetes diagnosis, that response is not unusual, and it is worth mentioning to your doctor. Stress and poor mental health can themselves worsen blood sugar control, creating a feedback loop that is worth breaking early.

1
PubMed Central. A1C level and future risk of diabetes: a systematic review
2
JAMA Internal Medicine. Risk of Progression to Diabetes Among Older Adults With Prediabetes
3
PubMed Central. Prediabetes diagnosis and treatment: A review
4
PubMed Central. Beta cell dysfunction and insulin resistance
5
PubMed Central. Relationship of Hemoglobin A1c with β Cell Function and Insulin Resistance in Newly Diagnosed and Drug Naive Type 2 Diabetes Patients
6
PubMed Central. Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction
7
PubMed Central. Association Between Hemoglobin A1c and Development of Cardiovascular Disease in Canadian Men and Women Without Diabetes at Baseline: A Population-Based Study of 608 474 Adults
8
PubMed Central. Years of potential life lost in pre-diabetes and diabetes mellitus: data from a 40-year follow-up of the Israel study on Glucose intolerance, Obesity and Hypertension
9
PubMed. Associations of Diabetes and Prediabetes With Mortality and Life Expectancy in China: A National Study
10
PubMed Central. Mortality Implications of Prediabetes and Diabetes in Older Adults
11
PubMed Central. Influence of Iron Deficiency Anemia on Hemoglobin A1C Levels in Diabetic Individuals with Controlled Plasma Glucose Levels
12
Diabetes & Metabolism Journal. Hemoglobin A1c May Be an Inadequate Diagnostic Tool for Diabetes Mellitus in Anemic Subjects
13
PubMed Central. Limited Agreement between Classifications of Diabetes and Prediabetes Resulting from the OGTT, Hemoglobin A1c, and Fasting Glucose Tests in 7412 U.S. Adults
14
PubMed Central. Comparison of A1C to Oral Glucose Tolerance Test for the Diagnosis of Prediabetes in Overweight and Obese Youth
15
PubMed Central. Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program
16
PubMed Central. Racial differences in performance of HbA1c for the classification of diabetes and prediabetes among US adults of non-Hispanic black and white race
17
Preventing Chronic Disease. HbA1c Performance in African Descent Populations in the United States With Normal Glucose Tolerance, Prediabetes, or Diabetes: A Scoping Review
18
PubMed Central. Effect of Aging on A1C Levels in Individuals Without Diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004
19
PubMed Central. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
20
PubMed Central. Interventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis
21
PubMed Central. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
22
PubMed Central. Resistance exercise training lowers HbA1c more than aerobic training in adults with type 2 diabetes
23
PubMed Central. The Effect of Traditional Aerobic Exercise and Sprint Interval Training on Insulin Resistance in Men With Prediabetes: A Randomised Controlled Trial
24
PubMed Central. Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)
25
PubMed Central. Intake of Pistachios as a Nighttime Snack Has Similar Effects on Short- and Longer-Term Glycemic Control Compared with Education to Consume 1-2 Carbohydrate Exchanges in Adults with Prediabetes: A 12-Wk Randomized Crossover Trial
26
PubMed. Metformin Should Not Be Used to Treat Prediabetes
27
The Journal of Clinical Endocrinology & Metabolism. Defining Continuous Glucose Monitor Time in Range in a Large, Community-Based Cohort Without Diabetes
28
Diabetes. 1929-P: Assessing Glycemic Variability by Continuous Glucose Monitoring: Implications for Prediabetes Subtypes and Potential Cardiovascular Risk
29
Journal of the Endocrine Society. THU303 The Associations Between Rest-Activity Parameters, Sleep-Disordered Breathing Severity And Glucose Metabolism In Patients With Prediabetes
30
PubMed Central. Fatigue, anxiety and depression in patients with prediabetes: a controlled cross-sectional study
31
Heliyon. Differences in mental health status between individuals living with diabetes, and pre-diabetes in Qatar: A cross-sectional study